According to the press release from Allergan, the manufacturer of Lumigan, the decision to withdraw Lumigan 0.03% was based solely on the preference from prescribers for the 0.01% formulation. There is no FDA-approved generic version of bimatoprost ophthalmic in the 0.01% concentration.